Psychogenic nonepileptic seizures (PNES) are relatively common occurrences in epilepsy centers [1] . These seizures consist of paroxysmal changes in responsiveness, movements, or behavior that superficially resemble epileptic seizures, but lack a neurobiological origin as in epileptic seizures and are not associated with electrophysiological epileptic changes [1] . It is clear that PNES lack a neurobiological origin similar to epileptic seizures, but it seems that there is a neurobiological basis for these events. Psychogenic nonepileptic seizures may be the result of neurobiological dysfunctions at specific brain networks and derangements in structural and functional brain connectivity of specific areas [2, 3] . As intrinsic brain abnormalities and dysfunctions are being suggested in the pathophysiology of PNES, it is not irrational to presume that genetic factors may play a role. However, there is no paper in the literature investigating or even suggesting this hypothesis.
The most obvious genetically determined risk factor for the development of PNES is gender [4] . There is a predominance of female gender among patients with PNES [1] . The reason for this gender predominance is not clear yet. Besides, patients with PNES often have psychiatric comorbidities. A lifetime history of other somatoform or dissociative disorders is found in more than 50% of patients who have PNES. Anxiety or psychotic and bipolar disorders are less common but are found more frequently in patients who have PNES than in the general population [4] . Interestingly, genetic factors play a significant role in most of the above comorbidities with PNES. In a recent study it was observed that specific single-nucleotide polymorphisms (SNPs) are associated with a range of psychiatric disorders (i.e., autism spectrum disorders, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia). In particular, variation in calcium-channel activity genes seemed to have pleiotropic effects on psychopathology. This analysis provided the first genome-wide evidence that individual and aggregate molecular genetic risk factors are shared between various psychiatric disorders. This finding, that genetic variants have cross-disorder effects, is an empirical step toward helping clinicians understand the common co-occurrence of psychiatric clinical phenotypes in individual patients. This implicates a specific biological pathway, voltage-gated calcium-channel signaling, as a contributor to the pathogenesis of several psychiatric disorders, and supports the potential of this pathway as a therapeutic target for psychiatric diseases [5] .
The relationship between genetic factors and PNES is obviously multifactorial in nature, if proved to be existent; genetic and environmental factors interactively determine their respective pathomechanism. In other words, many other factors codetermine whether PNES will develop in an individual, who supposedly has genetic predisposition to develop PNES. Finding the genetic bases and identification of genetic biomarkers of PNES have potentially important clinical implications in formulating better preventative, diagnostic and therapeutic approaches. Many years of work on treatment options for PNES have not made a great success in helping these patients. Medications and psychotherapies help some patients, but fail many others. Unfortunately, long-term studies suggest that many patients with PNES will continue to experience seizures despite neurological and psychotherapeutic care [6] . Failures to improve efficacy of treatment strategies in patients with PNES may reflect continued ignorance of the cellular and molecular mechanisms of PNES.
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